IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicated by severe thrombocytopenia and thrombosis can pose significant treatment challenges. Use of alternative anticoagulants in this setting may increase bleeding risks, especially in patients who have a protracted disease course. Additional t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chest
Autors principals: Padmanabhan, Anand, Jones, Curtis G., Pechauer, Shannon M., Curtis, Brian R., Bougie, Daniel W., Irani, Mehraboon S., Bryant, Barbara J., Alperin, Jack B., Deloughery, Thomas G., Mulvey, Kevin P., Dhakal, Binod, Wen, Renren, Wang, Demin, Aster, Richard H.
Format: Artigo
Idioma:Inglês
Publicat: American College of Chest Physicians 2017
Matèries:
Antithrombotic Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812774/
https://ncbi.nlm.nih.gov/pubmed/28427966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.03.050
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars